Acute Myeloid Leukemia Targets and Therapies

This template shows targeted therapies for acute myeloid leukemia organized around an AML cell into four strategies: proliferation inhibition with FLT3 inhibitors, differentiation therapy targeting PML-RARalpha, IDH1/2, HDAC, and HMT that pushes cells toward monocyte or granulocyte fates, and cell death induction using CAR T cells, bispecific antibodies, apoptosis inducers, antibody-drug conjugates, and liposome-mediated agents. Specific drug examples are listed under each category, such as midostaurin, venetoclax, and gemtuzumab ozogamicin.

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.